J. J. Walsh

发表

Twenty‐first century mast cell stabilizers

D. Finn, J. J. Walsh, D. F. Finn, 2013, British journal of pharmacology.

Isolation of (S)-(-)-2,3-dihydro-2,6-dimethyl-4H-benzopyran-4-one from roots of Leontopodium alpinum

H. Sheridan, I. Hook, J. J. Walsh, 1997 .

Departmental Differentials in the Predictive Validity of the Graduate Record Examination Aptitude Tests

G. Madaus, J. J. Walsh, J. Walsh, 1965 .

Optimising the Delivery of Tubulin Targeting Agents through Antibody Conjugation

J. J. Walsh, G. Stack, J. Walsh, 2012, Pharmaceutical Research.

Distinct determinants on collagen support a2,1 integrin-mediated platelet adhesion and platelet activation

S. Santoro, J. J. Walsh, W. Staatz, 2022 .

Steroid-based receptors with tunable cavities; stepwise and direct syntheses of a C3-symmetrical prototype

A. P. Davis, J. J. Walsh, J. Walsh, 1996 .

Nature’s Antidepressant for Mild to Moderate Depression: Isolation and Spectral Characterization of Hyperforin from a Standardized Extract of St. John’s Wort (Hypericum perforatum)

J. O'Brien, J. J. Walsh, B. Chrea, 2014 .

Synthesis and evaluation of dimeric 1,2,3,4-tetrahydro-naphthalenylamine and indan-1-ylamine derivatives with mast cell-stabilising and anti-allergic activity.

J. J. Walsh, J. Barlow, J. Walsh, 2010, European journal of medicinal chemistry.

Convergent total synthesis of the michellamines

M. Boyd, G. Bringmann, T. R. Kelly, 1994 .

A CONVERGENT TOTAL SYNTHESIS OF THE MICHELLAMINES

M. Boyd, G. Bringmann, T. R. Kelly, 1998 .

Synthesis, Screening and Pharmacokinetic Evaluation of Potential Prodrugs of Bupropion. Part One: In Vitro Development

P. O'Byrne, J. Gilmer, J. J. Walsh, 2014, Pharmaceuticals.

The aqueous stability of bupropion.

P. O'Byrne, J. Gilmer, J. J. Walsh, 2010, Journal of pharmaceutical and biomedical analysis.

Part Two: Evaluation of N-methylbupropion as a Potential Bupropion Prodrug

P. O'Byrne, J. Gilmer, J. J. Walsh, 2014, Pharmaceuticals.

A novel artemisinin-quinine hybrid with potent antimalarial activity.

A. Bell, J. J. Walsh, D. Coughlan, 2007, Bioorganic & medicinal chemistry letters.

Hybrid drugs for malaria.

A. Bell, J. J. Walsh, J. Walsh, 2009, Current pharmaceutical design.

Distinct determinants on collagen support alpha 2 beta 1 integrin-mediated platelet adhesion and platelet activation.

S. Santoro, J. J. Walsh, W. Staatz, 1991, Cell regulation.

Platelet interactions with fibronectin: divalent cation-independent platelet adhesion to the gelatin-binding domain of fibronectin.

S. Santoro, K. Winters, J. J. Walsh, 1993, Blood.

Tubulin-targeting agents in hybrid drugs.

J. J. Walsh, E. Breen, J. Walsh, 2010, Current medicinal chemistry.

Mast cell stabilisers.

J. J. Walsh, Tao Zhang, J. Barlow, 2016, European journal of pharmacology.

Synthesis and evaluation of 4-amino-3,4-dihydro-2H-naphthalen-1-one derivatives as mast cell stabilising and anti-inflammatory compounds.

J. J. Walsh, J. Barlow, J. Walsh, 2008, European journal of medicinal chemistry.

The alpha 2 beta 1 integrin cell surface collagen receptor binds to the alpha 1 (I)-CB3 peptide of collagen.

S. Santoro, T. Pexton, J. J. Walsh, 1990, The Journal of biological chemistry.

Amide bond formation via pentafluorothiophenyl active esters

A. P. Davis, J. J. Walsh, J. Walsh, 1994 .